ABA 0.00% $5.15 abano healthcare group limited

Ann: ASSET: ABA: Abano Announces Sale of Orthotics Business

  1. lightbulb Created with Sketch. 2
    • Release Date: 25/11/14 08:30
    • Summary: ASSET: ABA: Abano Announces Sale of Orthotics Business
    • Price Sensitive: No
    • Download Document  1.87KB
    					ABA
    25/11/2014 08:30
    ASSET
    PRICE SENSITIVE
    REL: 0830 HRS Abano Healthcare Group Limited
    
    ASSET: ABA: Abano Announces Sale of Orthotics Business
    
    Abano Healthcare Group (NZX:ABA) has announced the conditional sale of its
    orthotics business, The Orthotic Centre, to private investors. Settlement is
    planned for the end of January 2015 following completion of standard
    conditions.
    
    The business will be sold at book value, within the range of the recent Grant
    Samuels valuation and, after normal settlement adjustments and sale costs,
    will result in a small loss which will be reported in Abano's FY15 full year
    results.  The proceeds will be used to reduce debt and then reinvested into
    Abano's growth businesses, in particular dental.
    
    The Orthotic Centre is the leading provider of clinical orthotic services in
    New Zealand, with the majority of its revenue generated from DHB contracts.
    It holds multiple contracts around New Zealand and provides services from
    locations in Auckland, Hamilton, Wellington, Christchurch, Dunedin and
    Invercargill.
    
    Managing director of Abano, Mr Alan Clarke, said: "The Orthotic Centre's
    exposure to Government contracts is not compatible with Abano's investment
    criteria where we prefer healthcare businesses that are funded by private
    payment and operate on a fee for service basis. We have had a hold and
    maintain strategy in place for this business for several years as we have
    focused on other much larger sectors where there is significant scale and
    opportunity to add value."
    
    This is the last remaining business in Abano's rehabilitation sector,
    following the sale of its brain injury rehabilitation business in June 2012
    which also operated in a fixed price contract environment and was heavily
    reliant on DHB and ACC funding. For FY14, the Orthotic Centre provided 4% of
    Abano's gross revenues.
    
    ENDS
    End CA:00258022 For:ABA    Type:ASSET      Time:2014-11-25 08:30:57
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.